Category: Health Updates
-
First Pfizer COVID-19 vaccine recipient in UK gets second dose
U.K.’s first recipient of Pfizer and BioNTech’s coronavirus vaccine received her second dose of the shot on Tuesday, becoming the first person outside of clinical study to be fully inoculated, according to reports. Margaret Keenan, who received her first dose on Dec. 8, returned to Coventry’s University Hospital to receive the second The 91-year-old, who was the first in the world…
-
Doctor allergic to coronavirus vaccine details immediate reaction
The doctor in Massachusetts believed to be the first in the U.S. to suffer an adverse reaction to Moderna’s coronavirus vaccine said that the symptoms began within moments of the shot being administered. Dr. Hossein Sadrzadeh, of Boston Medical Center, received the vaccine on Thursday, and at first believed he was experiencing anxiety related to the shot, he…
-
Coronavirus symptoms to look out for
Though top public health experts have urged Americans to avoid traveling this holiday season due to the ongoing coronavirus pandemic, some may still be choosing to make plans for Christmas. If you plan to gather with those who live outside your household this holiday season, it’s good to be aware of how COVID-19 may present itself. On its website, the…
-
Doctor reportedly has severe allergic reaction to Moderna COVID-19 vaccine
A Boston doctor suffered a serious allergic reaction to Moderna’s coronavirus vaccine, the first of its kind documented, a report said Friday. Dr. Hossein Sadrzadeh, a geriatric oncologist at Boston Medical Center, became dizzy and felt his heart racing minutes after receiving the vaccine on Thursday, he told The New York Times. “It was the same anaphylactic reaction that I experience…
-
Chinese vaccines are poised to fill gap, but will they work?
With rich countries snapping up supplies of COVID-19 vaccines, some parts of the world may have to rely on Chinese-developed shots to try to conquer the outbreak. The question: Will they work? There is no outward reason to believe they won’t, but China has a history of vaccine scandals, and its drugmakers have revealed little…
-
CDC confirms COVID-19 vaccine allergic reactions, issues new guidance
The CDC said Saturday that it learned of severe allergic reactions to the COVID-19 vaccine, and now recommends if a person has “ever had a severe allergic reaction to any ingredient in a COVID-19 vaccine,” then they “should not get that specific vaccine.” This does not mean that everyone with bad allergies is barred from getting it. “CDC recommends that…
-
Demand is low for COVID-19 antibody drugs but shortages loom
U.S. health officials are seeing an astonishing lack of demand for COVID-19 medicines that may help keep infected people out of the hospital, drugs they rushed out to states over the past few weeks as deaths set new records. Red tape, staff shortages, testing delays and strong skepticism are keeping many patients and doctors from…
-
Who should COVID-19 vaccines go to next?
After the nation’s front-line medical workers and nursing home residents receive the initial COVID-19 vaccines, who should be next in line? A panelist of medical and public health experts, the Advisory Committee on Immunization Practices (ACIP), advising the Centers for Disease Control and Prevention (CDC) will weigh in and vote on the issue in an emergency meeting this weekend. The panelists are leaning toward…
-
Coronavirus antibodies present in babies born to mothers with COVID-19
Five babies born to mothers who had COVID-19 while they were pregnant were born with antibodies against the deadly virus, according to a new study out of Singapore. The study, published on Friday in the journal Annals of the Academy of Medicine, Singapore, followed 16 pregnant women between the ages of 23 and 36, who were all infected…
-
Johnson & Johnson’s single-dose COVID-19 vaccine trial reaches full enrollment
Johnson & Johnson announced it reached full enrollment for its late-stage single-dose coronavirus vaccine trial with about 45,000 participants. In a company statement, the health care giant said there is a high incidence of the virus circulating among the general populations where the U.S.-based study trials (called Ensemble) are underway, which will allow the company the data it needs.…
HEALTH STATUS 